Faron Pharmaceuticals Oy Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	13.53	9.5	6.88	6.99	6.85	4.11
Cash & Short-Term Investments	13.53	9.5	6.88	6.99	6.85	4.11
Cash Growth	-54.86%	38.22%	-1.65%	2.00%	66.82%	-41.80%
Other Receivables	-	0.28	0.23	0.91	1.42	1.27
Receivables	-	0.28	0.23	0.91	1.42	1.27
Prepaid Expenses	1.27	1.28	1.76	1.84	3.75	1.99
Other Current Assets	-	-0	0	-	-	-
Total Current Assets	14.81	11.07	8.87	9.73	12.02	7.37
Property, Plant & Equipment	0.25	0.3	0.2	0.33	0.21	0.38
Other Intangible Assets	1.11	1.11	1.09	1.15	0.9	0.57
Other Long-Term Assets	0.04	0.05	0.06	0.06	0.05	0.06
Total Assets	16.2	12.52	10.22	11.27	13.18	8.37
Accounts Payable	5.63	4.88	8.97	6.01	2.23	2.12
Accrued Expenses	1.23	1.46	2.4	2.45	4.06	3.82
Current Portion of Long-Term Debt	0.83	3.72	3.48	1.85	0.43	0.12
Current Portion of Leases	0.13	0.12	0.16	0.15	0.18	0.18
Other Current Liabilities	-	-	-	-	0.28	0.27
Total Current Liabilities	7.83	10.17	15.01	10.47	7.18	6.5
Long-Term Debt	21.31	8.09	9.42	11.1	2.92	2.73
Long-Term Leases	0.14	0.19	0.05	0.16	0.02	0.2
Other Long-Term Liabilities	3.18	3.84	0.9	1.01	0.15	0.79
Total Liabilities	32.45	22.28	25.38	22.75	10.26	10.22
Common Stock	2.69	2.69	2.69	2.69	2.69	2.69
Retained Earnings	-216.14	-197.42	-172.21	-143.71	-116.27	-96.56
Comprehensive Income & Other	197.2	184.97	154.36	129.55	116.49	92.02
Shareholders' Equity	-16.25	-9.76	-15.16	-11.48	2.92	-1.85
Total Liabilities & Equity	16.2	12.52	10.22	11.27	13.18	8.37
Total Debt	22.41	12.11	13.11	13.27	3.55	3.23
Net Cash (Debt)	-8.88	-2.61	-6.24	-6.28	3.31	0.88
Net Cash Growth	-	-	-	-	274.41%	-79.16%
Net Cash Per Share	-0.08	-0.03	-0.10	-0.11	0.07	0.02
Filing Date Shares Outstanding	111.95	104.62	68.79	59.81	53.23	46.9
Total Common Shares Outstanding	111.95	104.62	68.79	59.81	53.23	46.9
Working Capital	6.98	0.89	-6.14	-0.74	4.85	0.87
Book Value Per Share	-0.15	-0.09	-0.22	-0.19	0.05	-0.04
Tangible Book Value	-17.36	-10.87	-16.25	-12.63	2.02	-2.41
Tangible Book Value Per Share	-0.16	-0.10	-0.24	-0.21	0.04	-0.05
Machinery	-	0.03	0.03	0.06	0.06	0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.